The influence of hyperhomocysteinemia on graft patency after infrainguinal bypass surgery in the Dutch BOA study

Journal of Vascular Surgery

Volumn 36, Issue 2, 2002, Pages 336-340

  De Borst, G J ^a   Tangelder, M J D ^a   Algra, A ^a   Lawson, J A ^b   Banga, J D ^a   Eikelboom, B C ^a   Van Der Vliet, J A ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMSTELLAND HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BYPASS SURGERY; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; HYPERHOMOCYSTEINEMIA; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0036674098     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.125482     Document Type: Article

References (38)

1. Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease
2. Antiplatelet drugs in femoropoplitel vein bypasses: A multicenter trial
3. Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia; a review
4. Risk factors for occlusion of infrainguinal bypass grafts
5. Hyperhomocysteinemia: An independent risk factor for vascular disease
6. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
7. Homocysteine and risk of premature coronary heart disease. Evidence from a common gene mutation
8. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinaemia but not to vascular disease. The result of a meta-analysis
9. Heterozygosity for homocystinuria in pre-mature peripheral and cerebral occlusive arterial disease
10. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
11. Homocysteinaemia due to folate deficiency
12. Homocystinemia. Vascular injury and arterial thrombosis
13. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
14. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin Study): A randomised trial
15. Low-dose folic acid supplementation decreases plasma homocysteine concentration: A randomized trial
16. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection
17. Is hyperhomocysteinemia a risk factor for deepvenous thrombosis?
18. Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study
19. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene
20. Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries
21. Pathobiology of intimal hyperplasia
22. Vascular pathology of homocysteinaemia: Implications for the pathogenesis of arteriosclerosis
23. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
24. Hyperhomocysteinaemia is associated with impaired endothelium-dependent vasodilation in humans
25. Homocysteine may contribute to occlusive vascular disease by enhancing leukocyte-endothelial adhesion
26. Homocysteinaemia: Association of a metabolic disorder with vascular disease and thrombosis
27. Hyperhomocysteinaemia-induced vascular damage in the minipig
28. Increased cyclin dependent kinase in aortic tissue of rats fed homocysteine
29. Influence of serum lipoprotein(a) and homocyst(e)inc levels on graft patency after coronary bypass grafting
30. Infuence of systemic factors on pre-existing indmal hyperplasia and their effect on the outcome of infrainguinal arterial reconstruction with vein
31. Hyperhomocysteinaemia is a risk factor for vein graft stenosis
32. Homocysteine: An independent risk factor for the failure of vascular intervention
33. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
34. Hyperhomocysteinaemia and atherothrombosis
35. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
36. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinaemia
37. Lowering blood homocysteine with folic acid based supplements: Meta-analysis ofrandomised trials
38. Plasma homocysteine levels and mortality in patients with coronary artery disease